IL-6 further contributes to the liver’s acute-phase response by promoting C-reactive protein (CRP) synthesis, an inflammation marker linked to T2DM risk and poor glycemic control [8,13]. The gene discussed is CRP; the disease is type 2 diabetes mellitus.